Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: Role of activated macrophages and cytokines

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 12, 2004, Pages 2320-2325

  Kalinina, N ^a,b   Agrotis, A ^a   Antropova, Y ^b   DiVitto, G ^a   Kanellakis, P ^a   Kostolias, G ^a   Ilyinskaya, O ^b   Tararak, E ^b   Bobik, A ^a,c  

^a ALFRED HOSPITAL   (Australia)

^b INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Atherosclerosis; Cytokines; High mobility group box 1; Inflammation; Macrophages

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL LINE; CELLULAR DISTRIBUTION; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SMOOTH MUSCLE FIBER; UPREGULATION;

AORTA, ABDOMINAL; AORTA, THORACIC; ARTERIOSCLEROSIS; CELLS, CULTURED; CYTOKINES; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HMGB1 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; MACROPHAGE ACTIVATION; MACROPHAGES; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEIN TRANSPORT; RNA, MESSENGER; TUNICA INTIMA;

EID: 10644254917     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000145573.36113.8a     Document Type: Article

References (46)

1. Mosevitsky MI, Novitskaya VA, Iogannsen MG, Zabezhinsky MA. Tissue specificity of nucleo-cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functions. Eur J Biochem. 1989;185:303-310.
2. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol. 1999;19:5237-5246.
3. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ. HMG1 as a late mediator of endotoxin lethality in mice. Science. 1999;285:248-251.
4. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000;192:565-570.
5. Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ. HMGB1 as a DNA-binding cytokine. J Leukoc Biol. 2002;72:1084-1091.
6. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AF. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 2003;101:2652-2660.
7. Degryse B, Bonaldi T, Scaffidi P, Muller S, Resnati M, Sanvito F, Arrigoni G, Bianchi ME. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeletal reorganization in rat SMCs. J Cell Biol. 2001;152:1197-1206.
8. Fang WH, Yao YM, Shi ZG, Wu Y, Lu LR, Sheng ZY. The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury. Shock. 2002;17:329-333.
9. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000;2950-2954.
10. Kokkola R, Sundberg E, Ulfgren AK, Palmblad K, Li J, Wang H, Ulloa L, Yang H, Yan XJ, Furie R, Chiorazzi N, Tracey KJ, Andersson U, Harris HE. High mobility group box chromosomal protein-1: a novel proinflammatory mediator in synovitis. Arthritis Rheum. 2002;46:2598-2603.
11. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Reports. 2002;3:995-1001.
12. Rendon-Mitchell B, Ochani M, Li J, Wang H, Yang H, Susarla S, Czura C, Mitchell RA, Chen G, Sama AE, Tracey KJ, Wang H. IFN-γ induces high mobility box 1 protein release partially through a TNF-dependent mechanism. J Immunol. 2003;170:3890-3897.
13. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418:191-195.
14. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, Nagashima M, Lundh ER, Vijay S, Nitecki D, Morser J, Stern D, Schmidt AM. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of range and amphoterin in the developing nervous system. J Biol Chem. 1995;270:25752-25761.
15. Taguchi A, Blood D, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, Hofmann MA, Kislinger T, Ingram M, Lu A, Tanaka H, Hori O, Ogawa S, Stern DM, Schmidt AM. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature. 2000;405:354-358.
16. Huttunen HJ, Kuja-Panula J, Rauvala H. Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation. J Biol Chem. 2002;277:38635-38646.
17. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
18. Cipollone F, Iezzi A, Fazia M, Zucchelli M, Pini B, Cuccurullo C, De Cesare D, De Blasis G, Muraro R, Bei R, Chiarelli F, Schmidt AM, Cuccurullo F, Mezzetti A. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques. Circ. 2003;108:1070-1077.
19. Bucciarelli LG, Wendt T, Qu W, Lu Y, Lalla E, Rong LL, Goova MT, Moser B, Kislinger T, Lee DC, Kashyap Y, Stern DM, Schmidt AM. RAGE blockade stabilizes established atherosclerotic lesions in diabetic apolipoprotein E-null mice. Circ. 2002;106:2827-2835.
20. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insul W, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Circ. 1995;92:1355-1374.
21. Kalinina N, Agrotis A, Tararak E, Antropova Y, Kanellakis P, Ilyinskaya O, Quinn MT, Smirnov V, Bobik A. Cytochrome b558-dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2002;22:2037-2043.
22. Candido R, Forbes JM, Thomas MC, Thallas V, Dean RG, Burns WC, Tikellis C, Ritchie RH, Twigg SM, Cooper ME, Burrell LM. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res. 2003;92:785-792.
23. Ward MR, Agrotis A, Kanellakis P, Dilley R, Jennings G, Bobik A. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-β isoforms and their receptors following arterial injury. Arteriosder Thromb Vasc Biol. 1997;17:2461-2470.
24. Palumbo R, Sampaolesi M, De Marchis F, Tonlorenzi R, Colombetti S, Mondino A, Cossu G, Bianchi ME. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol. 2004;164:441-449.
25. Balnchette J, Jarmillo M, Olivier M. Signalling events involved in interferon-γ-inducible macrophage nitric oxide generation. Immunology. 2003;108:513-522.
26. Goetze S, Kineshior K, Meehan WP, Collins A, Fleek E, Hsueh WA, Law RE. TNF-α induces expression of transcription factors c-fos, Egr-1 and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2. Atherosclerosis. 2001;159:93-101.
27. Tokuda H, Hatakeyama D, Akamatsu S, Tanable K, Yoshida M, Shibata T, Kozawa O. Involvement of MAP kinases in TGF-β - stimulated vascular endothelial growth factor synthesis in osteoblasts. Arch Biochem Biophys. 2003;415:117-125.
28. Deb DK, Sassano A, Lekmine F, Majchrzak B, Bverma A, Kambhampati S, Uddin S, Rahman A, Fish EN, Platanias LC. Activation of protein kinase Cδ by IFN-γ. J Immunol. 2003;171:267-273.
29. Rahman JK, Anwar KN, Frey RS, Minshall RD, Malik AB. Tumor necrosis factor-α induces early-onset endothelial adhesivity by protein kinase Czeta-dependent activation of intercellular adhesion molecule-1. Circ Res. 2003;92:1089-1097.
30. Runyan CE, Schnaper HW, Poncelet AC. Smad3 and PKCδ mediate TGF-β-mediated collagen-1 expression in human mesangial cells. Am J Physiol. 2003;285:F413-F422.
31. Kawanaka H, Jones MK, Szabo IL, Baatar D, Pai R, Tsugawa K, Sugimachi K, Sarfeh IJ, Tarnawski AS. Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-α via the PI-3 kinase-Akt signaling pathway. Hepatology. 2002;35:393-402.
32. Kin G, Jun JB, Elkon KB. Necessary role of phosphatidylinositol 3-kinase in transforming growth factor-β mediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2002;46:12504-11511.
33. Navarro A, Anad-Apte B, Tanabe Y, Feldman G, Larner AC. A PI-3 kinase-dependent, STAT1-independent signaling pathway in interferon-stimulated monocyte adhesion. J Leukoc Biol. 2003;73:540-545.
34. Bianchi ME, Beltrame M, Paonessa G. Specific recognition of cruciform DNA by nuclear HMG1. Science. 1989;243:1056-1059.
35. Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S, Nakajima S, Maruyama I. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 2003;48:971-981.
36. Garcia A, Cereghini S, Sontag E. Protein phosphatase 2A and phosphatidylinositol 3-kinase regulate the activity of Sp1-responsive promoters. J Biol Chem. 2000;275:9385-9389.
37. Lum HK, Lee K-L, D. the human HMGB1 promoter is modulated by a silencer and an enhancer-containing intron. Biochimica et Biophysica Acta. 2000;1520:79-84.
38. Kim G, Jun JB, Elkon KB. Necessary role of phosphatidylinositol 3-kinase in transforming growth factor β-mediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2002;46:1504-1511.
39. Barsacchi R, Perrotta C, Bulotta S, Moncada S, Borgese N, Clementi E. Activation of endothelial nitric-oxide synthase by tumor necrosis factor-α: a novel pathway involving sequential activation of neutral sphingomyelinase, phosphatidylinositol-3′-kinase and Akt. Mol Phamacol. 2003;63:886-895.
40. Gardella S, Andrei C, Lotti LV, Poggi A, Torrisi MR, Zocchi MR, Rubartelli A. CD8+ T lymphocytes induce polarized exocytosis of secretory lysosomes by dendritic cells with release of interleukin-1β and cathepsin D. Immunobiology. 2001;98:2152-2159.
41. Tapper H, Sundler R. Protein kinase C and intracellular pH regulate zymosan-induced lysosomal enzyme secretion in macrophages. J Leukoc Biol. 1995;58:485-494.
42. Badewa AP, Heiman As. Inhibition of CCL11, CCL24 and CCL26-induced degranulation in HL-60 eosinophilic cells by specific inhibitors of MEK1/MEK2, p38 MAP kinase and PI 3-kinase. Immunopharmacol Immunotoxicol. 2003;25:145-157.
43. Huber M, Hughes MR, Krystal G. Thapsigargin-induced degranulation of mast cells is dependent on transient activation of phosphatidylinositol-3 kinase. J Immunol. 2000;165:124-133.
44. Stolovich M, Tang H, Hornstein E, Levy G, Cohen R, Bae SS, Birnbaum MJ, Meyuhas O. Transduction of growth or mitogen signals into translational activation of TOP mRNAs is fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but requires neither SK̂1 nor rpS6 phosphorylation. Mol Cell Biol. 2002;22:8101-8113.
45. Kumar V, Pandey P, Sabatini D, Kumar M, Majumder PK, Bharti A, Carmichael G, Kufe D, Kharbanda S. Functional interaction between RAFT1/FRAP/mTOR and protein kinase Cδ in the regulation of cap-dependent initiation of translation. EMBO J. 2000;19:1087-1097.
46. Petegnief V, Friguls B, Sanfeliu C, Sunol C, Planas AM. Transforming growth factor-α; attenuates N-methyl-D-aspartic acid toxicity in cortical cultures by preventing protein synthesis inhibition through an Erk1/2-dependent mechanism. J Biol Chem. 2003;278:29552-29559.